Evidence map›Paper›PMID 21221779›Full record

ArticleTransgenic research2011

Strategies for selection marker-free swine transgenesis using the Sleeping Beauty transposon system.

Daniel F Carlson, John R Garbe, Wenfang Tan, Mike J Martin, John R Dobrinsky, Perry B Hackett, Karl J Clark, Scott C Fahrenkrug

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Peripheral vascular atherosclerosis in a novel PCSK9 gain-of-function mutant Ossabaw miniature pig model.Translational research : the journal of laboratory and clinical medicine · 2018
    Article
  7. Article
  8. Review
  9. Article
  10. Engineering Large Animal Species to Model Human Diseases.Current protocols in human genetics · 2016
    Article
  11. Review
  12. Engineered Swine Models of Cancer.Frontiers in genetics · 2016
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Efficient TALEN-mediated gene knockout in livestock.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Daniel F CarlsonThe Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
John R Garbe
Wenfang Tan
Mike J Martin
John R Dobrinsky
Perry B Hackett
Karl J Clark
Scott C Fahrenkrug
University of Minnesota · USCenter Point · USInstitut thématique Génétique, génomique et bioinformatique · FRMayo Clinic · USMinitube (United States) · US

Funding

SB Transposons for Gene TherapyR01DK082516 · NIDDK · UNIVERSITY OF MINNESOTA · PI HACKETT, PERRY B. · 2010 to 2013
$1.3M
Engineering a CFTR Deficient Porcine Model of CFR56DK074010 · NIDDK · UNIVERSITY OF MINNESOTA · PI O'GRADY, SCOTT M. · 2006 to 2007
$498k
NIDDK NIH HHS R01 DK082516NIDDK NIH HHS R56 DK074010
6 · The paper itself

Abstract

Swine transgenesis by pronuclear injection or cloning has traditionally relied on illegitimate recombination of DNA into the pig genome. This often results in animals containing concatemeric arrays of transgenes that complicate characterization and can impair long-term transgene stability and expression. This is inconsistent with regulatory guidance for transgenic livestock, which also discourages the use of selection markers, particularly antibiotic resistance genes. We demonstrate that the Sleeping Beauty (SB) transposon system effectively delivers monomeric, multi-copy transgenes to the pig embryo genome by pronuclear injection without markers, as well as to donor cells for founder generation by cloning. Here we show that our method of transposon-mediated transgenesis yielded 38 cloned founder pigs that altogether harbored 100 integrants for five distinct transposons encoding either human APOBEC3G or YFP-Cre. Two strategies were employed to facilitate elimination of antibiotic genes from transgenic pigs, one based on Cre-recombinase and the other by segregation of independently transposed transgenes upon breeding.

Indexed as

Gene Transfer TechniquesAnimalsAPOBEC-3G DeaminaseBiomarkersBreedingCytidine DeaminaseDNA Transposable ElementsGenomeHumansIntegrasesSwineTransgenesTransposasesAPOBEC-3G DeaminaseAPOBEC3G protein, humanBiomarkersCre recombinaseCytidine DeaminaseDNA Transposable ElementsIntegrasesTransposases

Identifiers

PMID21221779
OpenAlexW2147291629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.